Next Article in Journal
Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents
Previous Article in Journal
Vitamin D and Influenza—Prevention or Therapy?
Open AccessArticle

Intrathecal Injection of Dual Zipper Kinase shRNA Alleviating the Neuropathic Pain in a Chronic Constrictive Nerve Injury Model

1
Institute of Biomedical Science, National Chung-Hsing University, Taichung 40244, Taiwan
2
Department of Neurosurgery, Taichung Veterans General Hospital, Taichung 40754, Taiwan
3
Department Life Sciences, Agriculture Biotechnology Center, National Chung Hsing University, Taichung 40244, Taiwan
4
Department of Medical Research, Taichung Veterans General Hospital, Taichung 40754, Taiwan
5
Department of Neurosurgery, University of Virginia, Charlottesville, VA 22901, USA
6
Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei 11257, Taiwan
*
Author to whom correspondence should be addressed.
These author contributed equally to this paper.
Int. J. Mol. Sci. 2018, 19(8), 2421; https://doi.org/10.3390/ijms19082421
Received: 26 July 2018 / Revised: 8 August 2018 / Accepted: 11 August 2018 / Published: 16 August 2018
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
Dual leucine zipper kinase (DLK) is a member of mitogen-activated protein kinase kinase kinase (MAP3K) family mainly involved in neuronal degeneration. However, the role of DLK signaling in the neuropathic pain has not yet been fully determined. Chronic constrictive injury (CCI) was conducted by four 3-0 chromic gut ligatures loosely ligated around the sciatic nerve. Escalated DLK expression over the dorsal root ganglion was observed from one to four rings of CCI. Remarkable expression of DLK was observed in primary dorsal root ganglion cells culture subjected to electrical stimulation and attenuated by DLK short hairpin RNA (shRNA) treatment. Intrathecal injection of DLK shRNA attenuates the expression of DLK over the dorsal root ganglion and hippocampus neurons and increased the threshold of mechanical allodynia and decreased thermal hyperalgesia. In CatWalk gait analysis, significant decreases of print area, maximum contact maximum intensity, stand phase, single stance, and regular index by CCI were alleviated by the DLK shRNA administration. In conclusion, the expression of DLK was up-regulated in chronic constrictive injury and attenuated by the administration of DLK shRNA, which paralleled the improvement of neurobehavior of neuropathic pain. The modulation of DLK expression is a potential clinic treatment option for neuropathic pain. View Full-Text
Keywords: dual zipper kinase; chronic constrictive injury; neuropathic pain dual zipper kinase; chronic constrictive injury; neuropathic pain
Show Figures

Graphical abstract

MDPI and ACS Style

Sheu, M.-L.; Chiang, C.-Y.; Su, H.-L.; Chen, C.-J.; Sheehan, J.; Pan, H.-C. Intrathecal Injection of Dual Zipper Kinase shRNA Alleviating the Neuropathic Pain in a Chronic Constrictive Nerve Injury Model. Int. J. Mol. Sci. 2018, 19, 2421.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop